Pages that link to "Q69914503"
Jump to navigation
Jump to search
The following pages link to Nicotine gum and haloperidol in Tourette's syndrome (Q69914503):
Displaying 13 items.
- Neuronal nicotinic receptors in the human brain (Q28141480) (← links)
- European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment (Q28972478) (← links)
- Human neuronal nicotinic receptors (Q29397943) (← links)
- Pharmacological options for the treatment of Tourette's disorder. (Q34107470) (← links)
- Gilles de la Tourette syndrome: symptomatic treatment based on evidence (Q34120073) (← links)
- The treatment of tics (Q34566420) (← links)
- Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond (Q36136238) (← links)
- The role of nicotine and nicotinic mechanisms in neuropsychiatric disease (Q36507405) (← links)
- Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders (Q36873932) (← links)
- Potentiation of haloperidol catalepsy by microinjections of nicotine into the striatum or pons in rats (Q48232785) (← links)
- Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. (Q48658270) (← links)
- 5-fluoronicotine, noranhydroecgonine, and pyridyl-methylpyrrolidine release acetylcholine and biogenic amines in rat cortex in vivo. (Q51594849) (← links)
- Nicotine and Tourette's syndrome (Q69375591) (← links)